Here are the DEF 14A proxy statements from Intuitive Surgical Inc. (ISRG) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ISRG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ISRG filings page.
Intuitive Surgical, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on April 30, 2026, at 3:00 p.m. Pacific. Proposals include electing ten directors, an advisory vote on executive pay, ratifying PricewaterhouseCoopers as auditor, and approving changes to the 2010 Incentive Award Plan.
The proxy details a planned leadership transition in which longtime CEO Gary S. Guthart became Executive Chair and David J. Rosa was promoted to Chief Executive Officer and director. The Board emphasizes strong governance, with eight of ten nominees independent, a separate Chair and CEO, a lead independent director, annual elections, proxy access, and strict anti‑hedging and anti‑pledging rules.
Operationally, for 2025 Intuitive reported revenue of $10,064.7 million, up 21% from 2024, and income from operations of $2,945.5 million, up 25%. Total da Vinci and Ion procedures reached 3,297,100, up 19%, supported by a growing installed base and multiple new FDA and international clearances for its da Vinci and Ion platforms.